who was the first scientist to initiate this engineering process?
Stanley G. Weinbaum
Genetic engineering
The term "genetic engineering" was first coined by Jack Williamson in his science fiction novel "Dragon's Island", published in 1951 – one year before DNA's role in heredity was confirmed by Alfred Hershey and Martha Chase, and two years before James Watson and Francis Crick showed that the DNA molecule has a double-helix structure – though the general concept of direct genetic manipulation was explored in rudimentary form in Stanley G. Weinbaum's 1936 science fiction story "Proteus Island".
what is the purpose for each of the following important techniques used in genetic engineering To change the genetic makeup of cells what is the definition of this branch of science? Direct manipulation of an organism's genes using biotechnology. what are the steps involved to execute this engineering process? Either isolating and copying the genetic material of interest using recombinant DNA methods or by artificially synthesising the DNA. what are the materials and equipment needed to carry out this engineering process? The gene is separated by using restriction enzymes to cut the DNA into fragments to amplify up the gene segment, which can then be extracted through gel electrophoresis. what are some of the things manufactured using this technique? Has applications in medicine, research, industry and agriculture and can be used on a wide range of plants, animals and microorganisms. mention any one controversy about this branch of science. Concerns involve GM crops and whether food produced from them is safe and what impact growing them will have on the environment.
wiki:7746584
Genetic engineering [SEP] History
One of the main recommendations from this meeting was that government oversight of recombinant DNA research should be established until the technology was deemed safe. In 1976 Genentech, the first genetic engineering company, was founded by Herbert Boyer and Robert Swanson and a year later the company produced a human protein (somatostatin) in "E.coli". Genentech announced the production of genetically engineered human insulin in 1978. In 1980, the U.S. Supreme Court in the "Diamond v. Chakrabarty" case ruled that genetically altered life could be patented. The insulin produced by bacteria was approved for release by the Food and Drug Administration (FDA) in 1982.